Listed times are in Central European Time (CET)

WELCOME TO DAY ONE

Matheus Dias NKI, Netherlands

Q&A: 12:25-12:35

Vesselina Cooke Novartis, USA

Q&A: 12:55-13:05

Proffered Paper 1

Q&A: 13:15-13:20

Proffered Paper 2

Q&A: 13:30-13:35

REFRESHMENT BREAK

FLASH TALKS 1

A selection of high-scoring abstracts presented as 3 minute flash talks.

Arun Unni Weill Cornell Medicine, USA

'Understanding the consequences of excess RAS pathway activity in cancer cells'

Q&A: 14:25-14:35

Proffered Paper 3

Q&A: 14:45-14:50

REFRESHMENT BREAK

FLASH TALKS 2

A selection of high-scoring abstracts presented as 3 minute flash talks.

Proffered Paper 4

Q&A: 15:30-15:35

Proffered Paper 5

Q&A: 15:45-15:50

Closing Keynote

Markus Muschen Yale School of Medicine, USA

'Targeted hyperactivation of oncogenic BCR-signaling in refractory B-cell malignancies'

Q&A: 16:15-16:30

SUMMARY AND CLOSE

Listed times are in Central European Time (CET)

WELCOME TO DAY TWO

Benoit Bilanges UCL Cancer Institute, UK

'Induction of cancer cell death by direct pharmacological PI3Kα activation under stress conditions: a proof-of-concept'

Q&A: 12:25-12:35

Eunice Cho The Broad Institute, USA

'Directed clonal evolution: Leveraging divergent MAPK inhibitor resistance for convergent hypersensitivity to MAPK hyperactivation'

Q&A: 12:55-13:05

Proffered Paper 6

Q&A: 13:15-13:20

Proffered Paper 7

Q&A: 13:30-13:35

REFRESHMENT BREAK

FLASH TALKS 3

A selection of high-scoring abstracts presented as 3 minute flash talks.

Proffered Paper 8

Q&A: 14:15-14:20

Andrew Intlekofer MSKCC, USA

'Enzyme hyperactivation to target oncometabolism'

Q&A: 14:40-14:50

REFRESHMENT BREAK

FLASH TALKS 4

A selection of high-scoring abstracts presented as 3 minute flash talks.

Kimberly Stegmaier Dana-Farber Cancer Institute, USA

Q&A: 15:40-15:50

Proffered Paper 9

Q&A 16:00-16:05

DISCUSSION SESSION

CONFERENCE SUMMARY AND CLOSE